- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04268641
Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients (POSIT-HEMI)
Evaluation of Positioning Protocols With an Adapted Equipment on a Wheelchair in Hemiplegic Patients Following a Stroke
Study Overview
Status
Intervention / Treatment
Detailed Description
The stroke is the main cause of hemiplegia in developed countries. Fifteen percent of people who say they have a stroke need, at home, a wheelchair to get from one room to another. The use of a wheelchair can cause postural disorders which can lead to pain, orthopedic deformity and pressure ulcers.
This study aims to assess the interest of using wheelchair positioning equipment (Seat back, Positioning cushion and Belt) on the decrease of postural disorders.
This decrease will be assessed after a standardized course, performed under three different conditions: with the positioning equipment (Positioning cushion and Seat back), with the positioning equipment and the belt and with the wheelchair alone.
Clinical tool used to assess the decrease is the Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0).
This study, which will be the first prospective, interventional, multicenter, controlled and randomized study, could pave the way for guidelines of good practice, for wheelchair positioning of hemiplegic patients in France
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Maryline DELATTRE
- Phone Number: 0033130754131
- Email: maryline.delattre@ght-novo.fr
Study Contact Backup
- Name: Véronique DA COSTA
- Phone Number: 0033130755069
- Email: veronique.dacosta@ght-novo.fr
Study Locations
-
-
-
Aincourt, France, 95510
- Groupement Hospitalier Intercommunal du Vexin
-
Garche, France, 92380
- Hôpital Raymond Poincaré
-
Lay-Saint-Christophe, France, 54690
- Institut Régional de Réadaptation
-
Lille, France, 59260
- Centre de l'ESPOIR
-
Mantes-la-Jolie, France, 78200
- Centre de Rééducation L'oiseau Blanc
-
Menucourt, France, 95180
- Centre de Rééducation et de Réadaptation Fonctionnelles
-
Toulouse, France, 31059
- Centre Hospitalier Universitaire de Toulouse
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hemiplegic patient following a stroke
- Hospitalized in a follow-up and rehabilitative care service, after hospital stays in a MCO service (neurology, neurosurgery or reanimation)
- With a planned exit from hospital (homecoming, residential care facilities, nursing home, Long Term Care Unit …)
- Patient whose wheelchair choice should be already done
- Patient who propels the wheelchair with the valid hand and/or valid foot
- Written informed consent (IC) obtained
- Patients with affiliation to the social security system
Exclusion Criteria:
- Good walk recovery (FAC scale >3)
- Wheelchair with a double hand rim
- Patient who cannot use his2 wheelchair independently
- Cognitive disorders which prevent the ability to well understanding the instructions
- Other pathology which can interfere with this protocol (Spinal disorder, morbid overweight (BMI>40…)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Use of positioning equipment order 1
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.
|
Materials used for the course :
|
Experimental: Use of positioning equipment order 2
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.
|
Materials used for the course :
|
Experimental: Use of positioning equipment order 3
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.
|
Materials used for the course :
|
Experimental: Use of positioning equipment order 4
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.
|
Materials used for the course :
|
Experimental: Use of positioning equipment order 5
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.
|
Materials used for the course :
|
Experimental: Use of positioning equipment order 6
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.
|
Materials used for the course :
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of pelvic posterior tilt
Time Frame: Immediately after the end of the procedure, an average of 1 day
|
The Primary Outcome Measure is the variation of the Degree of pelvic posterior tilt at the end of the three standardized course. These courses were performed with Standard Wheelchair, Standard Wheelchair + Seat back + Positioning cushion + Belt or with Standard Wheelchair + Seat back + Positioning cushion. The Degree of pelvic posterior tilt was measured using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion) |
Immediately after the end of the procedure, an average of 1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variation of Degree of pelvic posterior tilt
Time Frame: Baseline and immediately after the end of the procedure, an average of 1 day
|
The variation of the Degree of pelvic posterior tilt was measured between the beginning and the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
|
Baseline and immediately after the end of the procedure, an average of 1 day
|
Variation of degree of lateral inclination of the torso
Time Frame: Baseline and immediately after the end of the procedure, an average of 1 day
|
The variation of the degree of lateral inclination of the torso was measured between the beginning and the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
|
Baseline and immediately after the end of the procedure, an average of 1 day
|
Variation of the degree of Pelvis obliquity
Time Frame: Baseline and immediately after the end of the procedure, an average of 1 day
|
The variation of the degree of Pelvis obliquity was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 =moderate and 3 = severe retroversion)
|
Baseline and immediately after the end of the procedure, an average of 1 day
|
Degree of lateral inclination of the torso
Time Frame: Immediately after the end of the procedure, an average of 1 day
|
The degree of lateral inclination of the torso was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
|
Immediately after the end of the procedure, an average of 1 day
|
Degree of Pelvis obliquity
Time Frame: Immediately after the end of the procedure, an average of 1 day
|
The degree of Pelvis obliquity was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
|
Immediately after the end of the procedure, an average of 1 day
|
Measure of patient's satisfaction
Time Frame: Immediately after the end of the procedure, an average of 1 day
|
The satisfaction of patient was measured with a satisfaction questionnaire scale based on ease of movement, wheelchair comfort and pain during the course.
For each item, patient ticks : Very satisfied, Satisfied, Neither satisfied or unsatisfied, Unsatisfied or Very unsatisfied
|
Immediately after the end of the procedure, an average of 1 day
|
Ability to achieve the whole course
Time Frame: Immediately after the end of the procedure, an average of 1 day
|
Binary criteria (Yes / No)
|
Immediately after the end of the procedure, an average of 1 day
|
Adverse event collect
Time Frame: Immediately after the end of the procedure, an average of 1 day
|
Total number of adverse event
|
Immediately after the end of the procedure, an average of 1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nadine Pellegrini, Groupement Hospitalier Intercommunal du Vexin
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GHIV0417
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemiplegia and/or Hemiparesis Following Stroke
-
Sahel Taravati, M.D.CompletedHemiplegia and/or Hemiparesis Following StrokeTurkey
-
Istituti Clinici Scientifici Maugeri SpACompletedUpper Extremity Injury | Hemiplegia and/or Hemiparesis Following StrokeItaly
-
Loma Linda UniversityCompletedHemiplegia and/or Hemiparesis Following StrokeUnited States
-
Idaho State UniversityActive, not recruitingUpper Extremity Paresis | Hemiplegic Cerebral Palsy | Hemiplegia and/or Hemiparesis Following StrokeUnited States
-
WandercraftRecruitingCerebrovascular Disorders | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic | Hemiparesis | Cerebrovascular Accident | Hemiparesis;Poststroke/CVA | Stroke, Subacute | Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Germany, France, Spain
-
The University of Texas Health Science Center,...Otto Bock Healthcare Products GmbHCompletedHemiparesis Due to Stroke | Hemiplegia Due to StrokeUnited States
-
University of EssexAzienda Sanitaria dell' Alto Adige; Landeskrankenhaus HochzirlRecruitingStroke/Brain Attack | Stroke, Cerebrovascular | Hemiplegia and HemiparesisItaly
-
Pavlos KitixisActive, not recruitingHemiplegia and HemiparesisGreece
-
Spanish National Research CouncilHospital Beata María AnaCompletedHemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Spain
-
Beijing Tiantan HospitalCompletedHemiplegia Following Ischemic StrokeChina
Clinical Trials on Arm 1
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.Completed
-
VA Office of Research and DevelopmentCompletedSpinal Cord InjuriesUnited States
-
Morehouse School of MedicineNational Cancer Institute (NCI)UnknownColorectal CancerUnited States
-
The University of Texas Health Science Center,...Brighter BitesRecruiting
-
Children's Cancer Hospital Egypt 57357CompletedPediatric Brain Stem GliomaEgypt
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes MellitusUnited States
-
MD Stem CellsEnrolling by invitationSpinal Cord Diseases | Spinal Cord Injuries | SCI - Spinal Cord Injury | Paraplegia | Spinal Cord Compression | Spinal Cord Ischemia | Paraplegia, Spinal | Paraplegia; Traumatic | Spinal Paralysis | Paraplegia/ParaparesisUnited States
-
Norwegian University of Science and TechnologyHelse Nord-Trøndelag HFCompletedLow Back PainNorway
-
Abbott NutritionCompleted
-
Boston Scientific CorporationCompletedSudden Cardiac DeathUnited States, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Austria, Italy